1/15/2016

Fat Emulsion

Products Affected - Description

- Intralipid emulsion, Baxter, 20%, 100 mL Biofine container, 10 count, NDC 00338-0519-58
- Intralipid emulsion, Baxter, 20%, 1000 mL Biofine container, 6 count, NDC 00338-0519-14
- Intralipid emulsion, Baxter, 20%, 250 mL Biofine container, 10 count, NDC 00338-0519-09
- Intralipid emulsion, Baxter, 20%, 500 mL Biofine container, 12 count, NDC 00338-0519-13
- Intralipid emulsion, Baxter, 30%, 500 mL Biofine container, 12 count, NDC 00338-0520-13
- Liposyn III emulsion, Pfizer, 10%, 250 mL glass bottle, 12 count, NDC 00409-9790-02
- Liposyn III emulsion, Pfizer, 10%, 500 mL glass bottle, 12 count, NDC 00409-9790-03
- Liposyn III emulsion, Pfizer, 20%, 250 mL glass bottle, 12 count, NDC 00409-9791-02
- Liposyn III emulsion, Pfizer, 20%, 500 mL glass bottle, 12 count, NDC 00409-9791-03
- Liposyn III emulsion, Pfizer, 30%, 500 mL glass bottle, 12 count, NDC 00409-6892-03
- Nutrilipid emulsion, BBraun, 20%, 1000 mL flexible container, 8 count, NDC 00264-4460-00
- Nutrilipid emulsion, BBraun, 20%, 250 mL flexible container, 12 count, NDC 00264-4460-30
- Nutrilipid emulsion, BBraun, 20%, 500 mL flexible container, 12 count, NDC 00264-4460-10

Reason for the Shortage

- Baxter cannot provide a reason for the shortage of Intralipid.
- Baxter transitioned Intralipid from Excel containers to Biofine containers in August 2015.
- BBraun has limited market share.
- Hospira has Liposyn III on shortage due to manufacturing delays.

Estimated Resupply Dates

- Baxter has cancelled all Intralipid orders in Biofine containers. Limited quantities may be available for direct order of Intralipid in Excel containers. There is no estimated release date for additional information.
- BBraun may have limited supply of Nutrilipid available.
- Hospira has all Liposyn III presentations on long-term back order and the company cannot estimate a release date.

Alternative Agents & Management

- The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) has "Parenteral Nutrition Intravenous Fat Emulsions Product Shortage Considerations". Detailed information can be found at http://www.nutritioncare.org/Guidelines_and_Clinical_Resources/Clinical_Practice_Library/Parenteral_Nutrition_Intravenous_Fat_Emulsions_Product_Shortage_Considerations/

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.